TrialThe oncologist2025

Phase II study of avelumab and trastuzumab with FOLFOX chemotherapy in previously untreated HER2-amplified metastatic gastroesophageal adenocarcinoma.

Michael S Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.